MSCI
MSCI
$591.69
+5.00%
MSCI, Inc. operates as a global provider of critical decision-support tools and services for the investment community, spanning index construction and benchmarking, portfolio and risk analytics, ESG and climate data, and private-asset real estate reporting. Its competitive identity rests on the MSCI Index franchise, an entrenched standard for global equity benchmarking with roughly $18 trillion in benchmarked assets and over $2.3 trillion in ETF assets linked to its indexes, giving it a quasi-monopolistic, subscription-based moat with exceptionally high recurring revenue and margins. The current investor narrative centers on whether the company can reaccelerate organic growth after a stretch of decelerating top-line momentum, with the most recent quarter showing revenue growth of 12.2% year-over-year and a return to double-digit expansion, while debate persists over the durability of index fee growth tied to market levels, the trajectory of the ESG and climate segment, and the impact of an aggressive buyback-and-dividend capital return program funded partly by debt. Attention is also focused on the stock's notable underperformance versus the broader market over the past year, which has left valuation and sentiment at an inflection point ahead of the next earnings cycle.…
MSCI
MSCI
$591.69
Related headlines
Investment Opinion: Should I buy MSCI Today?
Rating: Buy. The core thesis is that MSCI's quasi-monopolistic index franchise, with roughly $18 trillion in benchmarked assets and over $2.3 trillion in ETF assets linked to its indexes, is reaccelerating to 12.21% revenue growth while trading at a forward PE of 25.34x that is reasonable for a business with 82.71% gross margins and 56.23% operating margins. The analyst consensus is 'strong_buy' (mean 1.5 across 17 analysts) with an average target price of $672.94, implying +18.3% upside from $569.08, and the low target of $570.00 sits essentially at the current price, limiting downside relative to the average target.
The supporting evidence is compelling: revenue grew 12.21% year-over-year in Q2 2026 to $867.0 million, up sequentially from $850.8 million in Q1 2026 and $822.5 million in Q4 2025; gross margin of 82.71% and operating margin of 56.23% are far superior to the Financial Data & Stock Exchanges industry's typical mid-to-high-teens to low-20s PE and 4–6x PS peers; TTM free cash flow of $1.598 billion funds a 1.26% dividend yield with a 46.3% payout ratio and continued buybacks; and the forward PE of 25.34x versus trailing 36.82x implies 31% earnings growth, consistent with consensus EPS of $32.38. The PEG of 3.48 is rich, but the quality premium is defensible given the franchise's recurring revenue and pricing power.
The biggest risks that could invalidate the thesis are: (1) a market-level decline that compresses index fees and the multiple simultaneously, given the beta of 1.237 and the Index segment's $511.0 million revenue concentration; (2) leverage-funded buybacks ($1.23 billion in Q3 2025) leaving limited flexibility with a current ratio of 0.899 and cash of $187.3 million; and (3) ESG and Climate segment pressure ($91.9 million of Q2 2026 revenue) from regulatory or political backlash. This Buy would upgrade to a stronger conviction if revenue growth sustains above 12% for two more quarters with evidence of net new asset flow contribution, and would downgrade to Hold if growth decelerates below 10% or if the forward PE expands above 30x without matching earnings growth. On valuation, the stock is fairly valued to modestly undervalued relative to its own history (PS down from 91.9x in Q4 2021 to 47.2x) but at a premium to peers — a quality premium that is justified but leaves limited margin of safety.
Sign up to view all
MSCI 12-Month Price Forecast
The forward-looking view is bullish with medium confidence: the reacceleration to 12.21% revenue growth, elite margins, and robust $1.598 billion TTM free cash flow support the premium valuation, while the forward PE of 25.34x and the analyst average target of $672.94 provide a favorable risk/reward skew. The main uncertainty is whether index fee growth is structural (net new assets and pricing) or cyclical (market levels), given the Index segment's $511.0 million revenue concentration and the stock's beta of 1.237. I would upgrade to high confidence if Q3 2026 shows revenue growth above 12% with evidence of net new asset flow contribution, and would downgrade to neutral if growth decelerates below 10% or if the forward PE expands above 30x without matching earnings growth.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MSCI's 12-month outlook, with a consensus price target around $671.76 and implied upside of +13.5% versus the current price.
Average Target
$671.76
0 analysts
Implied Upside
+13.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$550 - $735
Analyst target range
Coverage is robust with 17 analysts, and the consensus is decisively bullish: the recommendation is "strong_buy" with a mean rating of 1.5 on a 1-to-5 scale, and the average target price of $672.94 implies roughly +18.3% upside from the current price of $569.08. The distribution of recent institutional ratings is uniformly positive — Wells Fargo, JP Morgan, Evercore ISI, B of A Securities, Barclays, Raymond James, and Morgan Stanley all carry Overweight, Outperform, Buy, or Strong Buy ratings — with the notable upgrade being Wells Fargo's move from Equal Weight to Overweight on May 27, 2026, and no downgrades in the visible record. This consensus leans strongly bullish and stands in contrast to the stock's -8.83% one-year relative underperformance, suggesting analysts view the recent weakness as a buying opportunity rather than a structural deterioration.
The target range spans $570.00 to $735.00, a spread of $165 or roughly 29% of the average target, which signals meaningful dispersion in assumptions. The high target of $735.00 implies approximately 29.2% upside and likely assumes multiple expansion back toward historical highs alongside sustained 12%+ revenue growth and continued margin expansion, while the low target of $570.00 — essentially at the current price — prices in flat-to-modest growth, potential index fee pressure from market-level declines, and limited multiple support. The tight clustering of recent ratings around Overweight with no downgrades suggests strong conviction in the franchise, but the wide target spread and the fact that the low target sits at the current price indicate that the downside case is not fully discounted; with consensus revenue of $4.77 billion and EPS of $32.38, the stock's forward PE of 25.34x versus the average target implies analysts see the current multiple as attractive relative to the quality of the franchise.
Bulls vs Bears: MSCI Investment Factors
The bull case currently has stronger evidence: revenue reaccelerated to 12.21% year-over-year growth in Q2 2026, margins are elite and stable (82.71% gross, 56.23% operating), free cash flow is robust at $1.598 billion TTM, and all 17 analysts rate the stock a strong buy with an average target of $672.94 (+18.3% upside). The bear case rests on the stock's persistent relative underperformance (-8.83% versus the S&P 500 over one year), a premium valuation (36.82x trailing PE, 25.93x EV/EBITDA, PEG of 3.48) that leaves little room for error, and leverage-funded buybacks that have produced negative book equity. The single most important tension is whether the 12.2% revenue growth is structural — driven by net new asset flows and pricing — or cyclical, tied to market-level appreciation; if the former, the premium multiple is justified and the stock re-rates toward the $735 high target, but if the latter, a market pullback could compress both index fees and the multiple simultaneously.
Bullish
- Reaccelerating revenue growth: Q2 2026 revenue of $867.0 million grew 12.21% year-over-year versus $772.7 million in Q2 2025, and marked a sequential increase from Q1 2026's $850.8 million and Q4 2025's $822.5 million. This return to double-digit expansion, if sustained, underpins a durable compounding thesis for the subscription-based index franchise.
- Elite, stable profitability: Q2 2026 gross margin was 82.71%, operating margin 56.23%, and net margin 39.4%, with EBITDA of $530.0 million (61.1% of revenue). Margins have been remarkably consistent across eight quarters (gross margin 81.66%–83.33%), reflecting the operating leverage of a business with minimal marginal cost of delivery.
- Strong analyst consensus and upside: All 17 covering analysts carry a consensus 'strong_buy' rating (mean 1.5), with an average target price of $672.94 implying +18.3% upside from $569.08. Recent ratings from Wells Fargo, JP Morgan, Evercore ISI, B of A, Barclays, Raymond James, and Morgan Stanley are uniformly positive, with no downgrades in the visible record.
- Robust free cash flow and capital returns: TTM free cash flow is $1.598 billion, with Q2 2026 FCF of $385.8 million, supporting $168.4 million of Q2 buybacks and a dividend with a 46.3% payout ratio and 1.26% yield. Interest coverage of 6.87x on $71.0 million of quarterly interest expense is manageable against $530.0 million of EBITDA.
Bearish
- Persistent relative underperformance: MSCI has gained only 6.70% over the trailing year versus 15.53% for the S&P 500, a relative strength of -8.83%, and is down 9.48% over three months versus the index's +2.69% (relative strength -12.17%). Year-to-date the stock is up just 0.68% versus 11.93% for the S&P 500, confirming a flat, choppy tape.
- Premium valuation leaves little room for error: The trailing PE of 36.82x, forward PE of 25.34x, EV/EBITDA of 25.93x, and PS of 14.12x all sit at a premium to the Financial Data & Stock Exchanges industry's typical mid-to-high-teens to low-20s PE and 4–6x PS. The PEG of 3.48 suggests that even after accounting for growth, the stock commands a rich multiple.
- Leverage-funded buybacks impair flexibility: Negative book equity from sustained buybacks ($1.23 billion in Q3 2025, $414.8 million in Q1 2026) produces a debt-to-equity ratio of -2.39 and ROE of -45.3%, while the current ratio of 0.899 and cash balance of $187.3 million indicate reliance on recurring cash generation rather than a liquidity buffer. Leverage-funded buybacks at elevated valuations could impair flexibility if growth slows.
- Index fee growth tied to market levels: The Index franchise is the dominant engine at $511.0 million of Q2 2026 revenue, and a meaningful portion of its fee growth is tied to market-level appreciation rather than net new asset flows and pricing. A market decline would directly pressure this cyclical, beta-like revenue stream, and the stock's beta of 1.237 amplifies the effect.
MSCI Technical Analysis
MSCI is in a range-bound consolidation phase with a modestly positive longer-term tilt, having gained 6.70% over the trailing year while the S&P 500 rose 15.53%, translating to a relative strength of -8.83% versus the index. At the current price of $569.08, the stock sits at roughly 47.4% of its 52-week range of $501.08 to $644.77, positioning it in the lower-middle half of the band rather than near either extreme. This mid-range positioning suggests neither momentum-driven overextension nor a capitulation-style value opportunity, but rather a market that has yet to resolve direction, with the 52-week high representing a 13.3% premium to the current price and the 52-week low a 12.0% cushion below.
Short-term momentum has turned constructive even as the intermediate trend remains weak: the stock is up 5.27% over the past month, outperforming the S&P 500's 1.22% gain by a relative strength of +4.05%, yet it is down 9.48% over three months versus the index's +2.69%, a relative strength of -12.17%. This divergence — a strong one-month bounce inside a negative three-month trend — is characteristic of a mean-reversion rally following the sharp July drawdown from the $637 area to the $550s, and it warrants caution until the three-month downtrend is broken. Year-to-date the stock is up only 0.68% versus 11.93% for the S&P 500, and the 0.09% six-month change confirms a flat, choppy tape; the most recent session's -1.05% decline on volume of roughly 884,000 shares suggests the bounce is meeting supply near the $575 level.
Key technical levels are well defined: support rests at the 52-week low of $501.08, with an intermediate shelf around $535–$540 established by the late-September and early-October lows, while resistance sits at the 52-week high of $644.77, with a nearer ceiling near $575–$580 where the stock has repeatedly stalled. A breakout above $580 on volume would signal the one-month recovery is maturing into a trend reversal, whereas a breakdown below $535 would confirm the three-month downtrend and open the path toward the $501 low. With a beta of 1.237, the stock is roughly 24% more volatile than the market, and a maximum drawdown of -18.07% over the period underscores that position sizing should account for amplified moves relative to the index.
Beta
1.24
1.24x market volatility
Max Drawdown
-18.1%
Largest decline past year
52-Week Range
$501-$645
Price range past year
Annual Return
+10.2%
Cumulative gain past year
| Period | MSCI Return | S&P 500 |
|---|---|---|
| 1m | +7.0% | +1.0% |
| 3m | +3.6% | +2.9% |
| 6m | -1.1% | +8.6% |
| 1y | +10.2% | +14.6% |
| ytd | +4.7% | +12.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MSCI Fundamental Analysis
MSCI's revenue trajectory is reaccelerating, with Q2 2026 revenue of $867.0 million representing 12.21% year-over-year growth versus $772.7 million in Q2 2025, and marking a sequential increase from Q1 2026's $850.8 million and Q4 2025's $822.5 million. The multi-quarter trend is clearly upward — revenue rose from $745.8 million in Q1 2025 to $793.4 million in Q3 2025 and $822.5 million in Q4 2025 — and the segment mix shows the Index franchise as the dominant engine at $511.0 million, followed by Analytics at $189.4 million, ESG and Climate at $91.9 million, and all other segments at $74.7 million. The 12.2% growth rate, if sustained, supports a durable compounding thesis, though investors should watch whether index revenue growth is driven by market-level appreciation (a beta-like exposure) versus net new asset flows and pricing, since the former is cyclical and the latter is structural.
Profitability is elite and stable: Q2 2026 net income was $342.0 million on a net margin of 39.4%, with gross margin of 82.71% and operating margin of 56.23%, and EBITDA of $530.0 million (61.1% of revenue). Margins have been remarkably consistent across the last eight quarters — gross margin ranged from 81.66% in Q1 2025 to 83.33% in Q1 2026, and operating margin from 50.55% to 56.42% — reflecting the operating leverage of a subscription-based data and index business with minimal marginal cost of delivery. The Q2 2026 net margin of 39.4% was slightly below Q1 2026's 47.7% (which benefited from a tax credit) but above Q2 2025's 39.3%, and the 54.67% operating margin reported in the valuation data confirms MSCI operates at profitability levels far above typical financial-data peers, consistent with its pricing power and high renewal rates.
Balance sheet and cash flow metrics require careful interpretation: the reported debt-to-equity ratio of -2.39 and ROE of -45.3% are artifacts of negative book equity caused by sustained buybacks (Q2 2026 repurchases of $168.4 million, Q1 2026 of $414.8 million, Q3 2025 of $1.23 billion), not signs of distress. Free cash flow remains robust at $1.598 billion TTM, with Q2 2026 FCF of $385.8 million and Q1 2026 of $278.0 million, while the current ratio of 0.899 and cash balance of $187.3 million indicate the company relies on its recurring cash generation rather than a large liquidity buffer. Interest coverage of 6.87x and interest expense of $71.0 million in Q2 2026 are manageable against $530.0 million of EBITDA, and the dividend payout ratio of 46.3% with a 1.26% yield leaves ample room for continued capital returns; the key risk is that leverage-funded buybacks at elevated valuations could impair flexibility if growth slows.
Quarterly Revenue
$867000000.0B
2026-06
Revenue YoY Growth
+12.2%
YoY Comparison
Gross Margin
82.7%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MSCI Overvalued?
Because MSCI is solidly profitable — Q2 2026 net income of $342.0 million and a net margin of 39.4% — the PE ratio is the appropriate primary metric, and the stock trades at a trailing PE of 36.82x versus a forward PE of 25.34x. The 31% compression between trailing and forward multiples implies the market expects meaningful earnings growth, consistent with consensus EPS estimates of $32.38 for the forward period versus the current trailing figure, and the PEG ratio of 3.48 suggests that even after accounting for growth, the stock commands a rich multiple. The EV/EBITDA of 25.93x and EV/Sales of 14.40x further confirm a premium valuation framework typical of high-margin, recurring-revenue data franchises.
Relative to the Financial Data & Stock Exchanges industry, MSCI's trailing PE of 36.82x and forward PE of 25.34x sit at a premium to the sector's typical mid-to-high-teens to low-20s multiple, while its PS ratio of 14.12x is well above the industry norm of roughly 4–6x for diversified exchange operators. The premium is defensible on quality grounds — gross margin of 82.71%, operating margin of 54.67%, and net margin of 38.36% are all far superior to peers — but the PEG of 3.48 and EV/EBITDA of 25.93x leave little room for execution error, meaning the stock is priced for continued double-digit growth and margin durability rather than for cyclical recovery.
Historically, MSCI's own valuation band has compressed: the PS ratio has fallen from 91.9x in Q4 2021 and 64.8x in Q4 2023 to 53.8x in Q4 2025 and 47.2x in Q2 2026, while the trailing PE has ranged from 65.2x in Q4 2021 to 24.3x in Q1 2026 and now 36.8x. On a price-to-free-cash-flow basis, the current 27.87x PCF and 105.97x price-to-FCF (per historical ratios) reflect the same pattern of multiple normalization from 2021 extremes, suggesting the stock is now in the middle-to-lower portion of its historical band rather than at bubble-era levels. This positioning implies the market is no longer pricing in the hyper-growth optimism of 2021 but still assigns a quality premium; a re-rating higher would require evidence of sustained 12%+ growth, while further de-rating risk exists if growth decelerates toward high single digits.
PE
36.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 28x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the company's reliance on recurring cash generation rather than a liquidity buffer: the current ratio of 0.899 and cash balance of $187.3 million are thin against $71.0 million of quarterly interest expense, and the negative debt-to-equity ratio of -2.39 and ROE of -45.3% are artifacts of aggressive buybacks ($1.23 billion in Q3 2025 alone) that have consumed equity. Interest coverage of 6.87x is manageable against $530.0 million of quarterly EBITDA, but the combination of leverage-funded repurchases at elevated valuations and a 46.3% dividend payout ratio leaves less flexibility if growth slows. Revenue concentration is another vulnerability: the Index franchise generated $511.0 million of Q2 2026's $867.0 million in revenue, and a meaningful portion of its fee growth is tied to market levels rather than net new asset flows, making the top line partly cyclical. Finally, the Q2 2026 net margin of 39.4% was slightly below Q1 2026's 47.7% (which benefited from a tax credit), illustrating that earnings can be volatile quarter to quarter even in a subscription business.
Market and competitive risks are dominated by valuation compression: at 36.82x trailing PE, 25.34x forward PE, 25.93x EV/EBITDA, and 14.12x PS, MSCI trades at a premium to the Financial Data & Stock Exchanges industry's typical mid-to-high-teens to low-20s PE and 4–6x PS, and its PEG of 3.48 leaves little room for execution error. The stock's beta of 1.237 means it is roughly 24% more volatile than the market, so a broad risk-off rotation would hit MSCI harder than the index, as evidenced by its -8.83% one-year relative underperformance and -12.17% three-month relative weakness. Competitive disruption risk exists in the ESG and Climate segment ($91.9 million of Q2 2026 revenue), where regulatory scrutiny and political backlash against ESG investing could pressure demand, and in the Analytics segment ($189.4 million), where software competitors could erode pricing. The recent news flow — including Michael Burry's high-profile short bet on semiconductors signaling a sentiment shift — highlights the broader risk that crowded, high-multiple quality names are vulnerable to a rotation if market leadership broadens.
In a worst-case scenario, a market-level decline would simultaneously compress index fees (the beta-like revenue stream tied to benchmarked assets) and the premium multiple, while leverage-funded buybacks would have less cash flow to support them. The stock's 52-week low of $501.08 represents a 12.0% decline from the current $569.08, and the analyst low target of $570.00 sits essentially at the current price, suggesting the downside case is not fully discounted. A more severe outcome — a 20%+ market drawdown combined with multiple compression toward the sector's low-20s PE — could push the stock toward the $501 low or below, implying a loss of roughly 12% to 15% from current levels; the maximum drawdown of -18.07% over the observed period underscores that position sizing should account for amplified moves relative to the index.
FAQ
The most severe risk is market-level exposure: the Index franchise generated $511.0 million of Q2 2026's $867.0 million revenue, and a meaningful portion of its fee growth is tied to benchmarked asset levels, so a market decline would directly pressure revenue while the beta of 1.237 amplifies the stock's move. Second is valuation compression: at 25.34x forward PE and 25.93x EV/EBITDA, a de-rating toward the sector's low-20s PE could erase a significant portion of the +18.3% analyst upside. Third is financial flexibility: leverage-funded buybacks ($1.23 billion in Q3 2025) have produced negative book equity (debt-to-equity of -2.39) and a current ratio of 0.899 with only $187.3 million in cash, limiting the buffer if growth slows. Fourth is company-specific ESG risk: the ESG and Climate segment's $91.9 million quarterly revenue is exposed to regulatory and political backlash against sustainable investing.
The 12-month forecast has three scenarios: a bull case (30% probability) targeting $672.94–$735.00 if revenue growth sustains above 12% with net new asset flow contribution and the market re-rates the stock; a base case (50% probability) targeting $570.00–$672.94 if growth moderates to 10–12% and the forward PE holds in the 25–30x range; and a bear case (20% probability) targeting $501.08–$570.00 if a market decline compresses index fees and the multiple de-rates. The base case is most likely, with the key assumption being that index fees grow in line with market levels and margins remain above 82% gross and 54% operating. The analyst average target of $672.94 aligns with the upper end of the base case and the lower end of the bull case, reflecting consensus confidence in the franchise.
MSCI trades at a trailing PE of 36.82x, forward PE of 25.34x, EV/EBITDA of 25.93x, and PS of 14.12x, which is a premium to the Financial Data & Stock Exchanges industry's typical mid-to-high-teens to low-20s PE and 4–6x PS. However, relative to its own history, the valuation has normalized significantly: the PS ratio has fallen from 91.9x in Q4 2021 to 47.2x in Q2 2026, and trailing PE from 65.2x to 36.8x, placing the stock in the middle-to-lower portion of its historical band. The PEG of 3.48 suggests the market is paying a rich price even after accounting for growth, implying expectations of sustained double-digit revenue growth and margin durability. The market is paying a quality premium that is defensible given 82.71% gross margins and recurring revenue, but the stock is fairly valued to modestly undervalued relative to its own history rather than cheap.
From a risk/reward perspective, MSCI offers an attractive setup: the average analyst target of $672.94 implies +18.3% upside from $569.08, while the low target of $570.00 sits essentially at the current price, limiting downside relative to the average. The stock trades at a forward PE of 25.34x, reasonable for a business with 82.71% gross margins and 12.21% revenue growth, and all 17 analysts rate it a strong buy. The biggest downside risk is a market-level decline that compresses index fees and the multiple simultaneously, with the 52-week low of $501.08 representing a 12.0% decline. It is a good buy for long-term investors with a 2–3 year horizon who can tolerate a beta of 1.237, particularly on dips toward the $535–$540 support, but less suited for short-term traders given the flat six-month tape (0.09% change).
MSCI is best suited for long-term investment: it is a mature growth compounder with a subscription-based moat, 12.21% revenue growth, 82.71% gross margins, and $1.598 billion in TTM free cash flow, and its 1.26% dividend yield with a 46.3% payout ratio provides modest income. The beta of 1.237 and maximum drawdown of -18.07% mean short-term trading carries amplified risk, and the flat six-month tape (0.09% change) with -9.48% three-month performance offers little momentum for traders. Earnings visibility is high given recurring revenue, but the stock's premium valuation (25.34x forward PE) means multiple compression can punish short holding periods. A suggested minimum holding period is 2–3 years to allow the reacceleration thesis to play out and to ride through market-level volatility in the index fee stream.